The effect of trichlormethiazide in autosomal dominant polycystic kidney disease patients receiving tolvaptan: a randomized crossover controlled trial
Crossref DOI link: https://doi.org/10.1038/s41598-021-97113-w
Published Online: 2021-09-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Uchiyama, Kiyotaka
Kitayama, Chigusa
Yanai, Akane
Ishibashi, Yoshitaka
Text and Data Mining valid from 2021-09-03
Version of Record valid from 2021-09-03
Article History
Received: 8 October 2020
Accepted: 17 August 2021
First Online: 3 September 2021
Competing interests
: The authors declare no competing interests.